Authors:
Simmgen, M
Newlands, ES
Southcott, BM
Vigushin, DM
Citation: M. Simmgen et al., Bilateral chylothorax due to retrosternal goiter in a patient with non-Hodgkin's lymphoma, MED ONCOL, 18(2), 2001, pp. 153-157
Authors:
Paradinas, FJ
Sebire, NJ
Fisher, RA
Rees, HC
Foskett, M
Seckl, MJ
Newlands, ES
Citation: Fj. Paradinas et al., Pseudo-partial moles: placental stem vessel hydrops and the association with Beckwith-Wiedemann syndrome and complete moles, HISTOPATHOL, 39(5), 2001, pp. 447-454
Authors:
Cole, LA
Shahabi, S
Butler, SA
Mitchell, H
Newlands, ES
Behrman, HR
Verrill, HL
Citation: La. Cole et al., Utility of commonly used commercial human chorionic gonadotropin immunoassays in the diagnosis and management of trophoblastic diseases, CLIN CHEM, 47(2), 2001, pp. 308-315
Authors:
Hancock, BW
Welch, EM
Gillespie, AM
Newlands, ES
Citation: Bw. Hancock et al., A retrospective comparison of current and proposed staging and scoring systems for persistent gestational trophoblastic disease, INT J GYN C, 10(4), 2000, pp. 318-322
Authors:
Francis, R
Bower, M
Brunstrom, G
Holden, L
Newlands, ES
Rustin, GJS
Seckl, MJ
Citation: R. Francis et al., Surveillance for stage I testicular germ cell tumours: results and cost benefit analysis of management options, EUR J CANC, 36(15), 2000, pp. 1925-1932
Authors:
Newlands, ES
Mulholland, PJ
Holden, L
Seckl, MJ
Rustin, GJS
Citation: Es. Newlands et al., Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors, J CL ONCOL, 18(4), 2000, pp. 854-859
Authors:
Fisher, RA
Khatoon, R
Paradinas, FJ
Roberts, AP
Newlands, ES
Citation: Ra. Fisher et al., Repetitive complete hydatidiform mole can be biparental in origin and either male or female, HUM REPR, 15(3), 2000, pp. 594-598
Authors:
Brock, CS
Young, H
O'Reilly, SM
Matthews, J
Osman, S
Evans, H
Newlands, ES
Price, PM
Citation: Cs. Brock et al., Early evaluation of tumour metabolic response using [F-18]fluorodeoxyglucose and positron emission tomography: a pilot study following the phase II chemotherapy schedule for temozolomide in recurrent high-grade gliomas, BR J CANC, 82(3), 2000, pp. 608-615
Authors:
Balesaria, S
Brock, C
Bower, M
Clark, J
Nicholson, SK
Lewis, P
de Sanctis, S
Evans, H
Peterson, D
Mendoza, N
Glaser, MG
Newlands, ES
Fisher, RA
Citation: S. Balesaria et al., Loss of chromosome 10 is an independent prognostic factor in high-grade gliomas, BR J CANC, 81(8), 1999, pp. 1371-1377
Authors:
Fossa, SD
Stenning, SP
Gerl, A
Horwich, A
Clark, PI
Wilkinson, PM
Jones, WG
Williams, MV
Oliver, RT
Newlands, ES
Mead, GM
Cullen, MH
Kaye, SB
Rustin, GJS
Cook, PA
Citation: Sd. Fossa et al., Prognostic factors in patients progressing after cisplatin based chemotherapy for malignant non-seminomatous germ cell tumours, BR J CANC, 80(9), 1999, pp. 1392-1399
Authors:
Newlands, ES
Foskett, MA
Seckl, MJ
Paradinas, FJ
Francis, R
Short, D
Fuller, S
Hall, JF
Citation: Es. Newlands et al., The management and outcome in patients presenting with twin/multiple pregnancies complicated by a complete hydatidiform mole (CHM) and patients presenting with partial hydatidiform mole (PHM), 7TH BIENNIAL MEETING OF THE INTERNATIONAL GYNECOLOGIC CANCER SOCIETY, 1999, pp. 43-47